Institutional & Family Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

A detailed history of Institutional & Family Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 330 shares of VRTX stock, worth $165,808. This represents 0.02% of its overall portfolio holdings.

Number of Shares

330

Previous 374 11.76%

Holding current value

$165,808

Previous $156,000 1.28%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	SELL	$392.81 - $485.53 $17,283 - $21,363	-44 Reduced 11.76%	330 $154,000
Q1 2024 May 08, 2024	SELL	$407.69 - $446.08 $15,899 - $17,397	-39 Reduced 9.44%	374 $156,000
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $7,546 - $9,034	-22 Reduced 5.06%	413 $168,000
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $6,763 - $7,249	-20 Reduced 4.4%	435 $151,000
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $4,401 - $4,926	-14 Reduced 2.99%	455 $160,000
Q1 2023 May 08, 2023	SELL	$283.23 - $323.1 $5,947 - $6,785	-21 Reduced 4.29%	469 $147,000
Q4 2022 Feb 08, 2023	SELL	$285.76 - $321.48 $4,000 - $4,500	-14 Reduced 2.78%	490 $141,000
Q3 2022 Nov 07, 2022	SELL	$273.83 - $305.53 $15,060 - $16,804	-55 Reduced 9.84%	504 $146,000
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $12,922 - $16,090	-55 Reduced 8.96%	559 $158,000
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $1,107 - $1,304	-5 Reduced 0.81%	614 $160,000
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $19,252 - $22,441	93 Added 17.68%	619 $133,000
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $3,726 - $4,969	18 Added 3.54%	526 $124,000
Q3 2020 Oct 30, 2020	BUY	$255.65 - $303.1 $22,497 - $26,672	88 Added 20.95%	508 $138,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $4,284 - $5,620	19 Added 4.74%	420 $122,000
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $5,393 - $6,690	-27 Reduced 6.31%	401 $95,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $833 - $1,119	-5 Reduced 1.15%	428 $94,000
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $166 - $187	-1 Reduced 0.23%	433 $73,000
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $1,975 - $2,284	12 Added 2.84%	434 $80,000
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $2,783 - $3,309	-17 Reduced 3.87%	422 $78,000
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $66,552 - $77,760	439 New	439 $72,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account

Institutional & Family Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History